[ad_1]
Ministry of Public Health Thailand reveals that Thailand has started producing the COVID-19 vaccine in the country, a vaccine that has inherited the production technology of “University of Oxford – AstraZeneca” with an annual production capacity of 200 million doses, The first batch is expected to be delivered in May 2021 and the vaccine will be ordered from a Chinese company. To deliver 2 million doses in February – April, with negotiations to supply more than 50 percent of Thais to receive free government vaccines in line with their targets.
Today (January 3) at the News Operations Center for Coronavirus 2019, Ministry of Public Health, Nonthaburi Province, Dr. Suphakit Sirilak, Director General of the Department of Medical Sciences Together with Dr. Nakorn Premsri, Director of the Institute National Vaccine and Dr. Songpol Dee Jongkit, Managing Director Siam Biso Co., Ltd. Announces Advances in Providing Vaccines to Prevent COVID-19
Dr. Supakit said that the Thai government by the Ministry of Public Health. They have cooperated with many parties. Assure citizens that they will receive their vaccinations at the latest in most countries. Since the middle of last year, the COVID-19 Vaccine Acquisition Committee for Thais has been prepared to investigate the objectives, how it works and there are mechanisms to achieve the vaccine. Since the results of the research are unknown, which vaccines will be successful. Set a free vaccination goal for Thais of at least 50% of the population or approximately 70 million doses by entering into a 26 million dose advance subscription agreement with AstraZeneca. Using technology from the University of Oxford, it is now in the process of transferring the production process to Siam BioScience. Deliveries are expected to begin in late May. Another 30 percent are in negotiations with the COVAX facility, concluding an agreement with a vaccine company that is expected to be available. Including negotiations with other companies such as Pfizer, Moderna, Chinese companies OR you can order more from AstraZeneca Also, there is good news that 2 million doses of the vaccine will be obtained from Sinovac China, approximately 200,000 doses at the end of February, 800,000 doses at the end March and 1 million at the end of April. Volume
Dr. Supakit went on to say that there are few vaccines at this time. Even countries that have started injecting and have started injecting cannot inject all at once. It is not a product that will be readily available on the market. It is important to have a quality and safety control system. Vaccines will not be purchased from substandard factories. Phase 3 trial results are not endorsed by private companies to be sold and must be registered with the FDA, and more importantly, each batch released must be certified by the Department of Medical Sciences. Is consumer protection Thailand has a mechanism to review the committee through a process that confirms that there are sufficient standards. Ensuring Thais are vaccinated quickly and safely, even when they have received the vaccine. It will operate in accordance with the principles of vaccine administration. There is a target audience. Vaccination methods Service preparation Quality control From start to finish
Nakorn Premsri, director of the National Vaccine Institute, said that there is currently a COVID-19 vaccine worldwide. It has been approved for emergency use (USA) by 9 manufacturers, 4 vaccines such as mRNA, Viral Vector, Inactivated and Protein Subunit in Thailand will accept the registration with Phase 3 effect with clear effectiveness. Only three registered and recognized vaccines are Pfizer, Moderna and AstraZeneca. The rest (AstraZeneca) is an emergency registry using only Phase 2 results, although previously recorded Chinese and Russian vaccines from July to August 2020 do not have an official Phase 3 effect. Get Out AND all COVID- 19 currently available are not finalized yet. Both Pfizer and Modena continued to collect data to look at the effectiveness of the vaccine after three months. While AstraZeneca’s Thai subscriptions have been approved for the use of emergency vaccines by the British regulator on December 30, 2020.
The news that 10 countries around the world received more than 5 million doses of the vaccine were due to advance vaccine stocks from July to August 2020. Preliminary results of the efficacy and safety studies of the vaccines are not known. vaccinations There is a very high risk that the vaccine will not be successful and you will not get vaccinated. For thailand Advance reservations for Phase III vaccines, at risk of not receiving them. It was based on energy emission under the National Vaccine Safety Act, BE2561 on October 12, 2020 and reserved the vaccine in November 2020.
Dr. Nakorn went on to say on the question of the chances of more vaccinations by January 2021. But will it reach 100 million doses or not? This depends on the number of vaccines available. Since there are currently a limited number of vaccines. Each company is expanding its production capacity to suit the entire population of the world. This is a great opportunity to learn more about vaccine safety. When vaccines are used in large populations Furthermore, Thailand does not focus solely on AstraZeneca vaccines. The Ministry of Public Health has established a vaccination policy to cover no less than 50% of the Thai population in 2021, which has been implemented in various ways. There are currently discussions with several other vaccine manufacturers. It was not specified that it would collaborate only with a particular manufacturer.
However, the private sector is not prevented from importing vaccines for sale in the country. Following a process that must be approved by the FDA to ensure that the vaccine is effective, safe, and meets international standards. In addition, there is a plan to support the registry of vaccines for use in an emergency, the FDA has already prepared and established guidelines for the emergency registry. You can request this information from the Food and Drug Administration
Dr. Songpol Dee Chongkit Managing Director Siam Biso Co., Ltd. said Siam BioScience. Knowledge and technology received from AstraZeneca Company Since October 7, 2020, we have prepared the facility, plant, material, equipment, equipment, machinery, currently in the production testing phase in order to obtain good quality vaccines. There is a standard equivalent to the central standard. Which is the same standard as AstraZeneca’s global manufacturing plants.There is a production capacity of around 200 million doses per year or 15-20 million doses per month, to be tested in 5 production cycles, each cycle of production 14 days apart and takes 120 days (4 months) to produce 60 days. And another 60 days for quality analysis The first round took place on December 16 last. Production of the second round, when the production is completed 5 rounds, the results will be sent to the Food and Drug Administration for approval. However, the most important thing in vaccine production is quality and reliability. Make people trust efficient and safe This is as planned and progress will be reported regularly.
